Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.

Authors:
Li B; Li Y; Zhou H; Xu Y; Cao Y and 17 more

Journal:
Hepatology

Publication Year: 2023

DOI:
10.1097/HEP.0000000000000553

PMCID:
PMC10789383

PMID:
37540187

Journal Information

Full Title: Hepatology

Abbreviation: Hepatology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability statement transcriptomic data are available at the gene expressionomnibus (gse202069"

Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST Wajahat Mehal consults for Pfizer. The remaining authors have no conflicts to report."

Evidence found in paper:

"FUNDING INFORMATION This work was supported by grants from the National Natural Science Foundation of China (No. 82002509, 82173129, 81871967, 82103384, and 82103453), China Postdoctoral Science Foundation (No.2019M661803), Social Development Foundation of Jiangsu Province of China (No. BE2018604), Jiangsu Provincial Medical Talent, the Special Fund of Nanjing Health Science and Technology Development (No. YKK21079), the Start-up Funding for Talent Introduction of Drum Tower Hospital (RC2023-032), and the Fundings for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2021-LCYJ-MS-12)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025